Literature DB >> 25970361

Secondary osteosarcoma: is there a predilection for the chondroblastic subtype?

Jordan P Barker, Michael J Monument, Kevin B Jones, Angelica R Putnam, R Lor Randall.   

Abstract

Osteosarcoma is the most common form of primary bone cancer in the adolescent and young adult patient population. Outcomes in patients with secondary osteosarcoma are inferior compared with outcomes in patients with primary osteosarcoma. The goal of this study was to investigate whether there is a predilection for the chondroblastic histologic subtype in secondary osteosarcoma. A retrospective chart review was performed to identify cases of secondary osteosarcoma treated at 1 institution from 1991 to 2012. Histologic subtypes were evaluated by a pathologist, and a review of the literature was also performed to identify the histologic subclassification of additional series of secondary osteosarcomas. Of a total of 131 cases of osteosarcoma, 9 (6.9%) were identified as a secondary malignancy. Only 2 cases (22%) were identified as chondroblastic variants, although 6 (67%) showed some degree of chondroid differentiation. Of the 3 cases meeting the criteria for postradiation osteosarcoma, 2 (67%) were identified as chondroblastic variants and all 3 showed some degree of chondroid differentiation. Five other studies evaluating histologic subtypes in postradiation osteosarcoma showed a cumulative frequency of 20% for the chondroblastic variant. Although the study results did not support the hypothesis of an association between secondary osteosarcoma and the chondroblastic subtype, the high proportion of cases of postradiation osteosarcoma with the chondroblastic subtype and the even higher proportion showing some degree of chondroid differentiation are noteworthy features of this disease. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 25970361     DOI: 10.3928/01477447-20150504-51

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.

Authors:  Armin Arshi; Justin Sharim; Don Y Park; Howard Y Park; Hamed Yazdanshenas; Nicholas M Bernthal; Arya N Shamie
Journal:  Spine J       Date:  2016-11-14       Impact factor: 4.166

2.  Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis.

Authors:  Enrico Martin; Joeky T Senders; P Valerie Ter Wengel; Timothy R Smith; Marike L D Broekman
Journal:  Acta Neurochir (Wien)       Date:  2018-12-21       Impact factor: 2.216

3.  A nomogram for predicting cancer-specific survival in patients with osteosarcoma as secondary malignancy.

Authors:  Yanqi He; Han Liu; Shuai Wang; Jianjun Zhang
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.